Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100.

Jesús M Cesar1, Dunia de Miguel, Angel García Avello

  • 1Department of Hematology, Hospital Ramón y Cajal, Madrid, Spain.

American Journal of Clinical Pathology
|June 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study.

Clinical lymphoma, myeloma & leukemia·2023
Same author

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience.

Cancers·2022
Same author

Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study.

Clinical lymphoma, myeloma & leukemia·2021
Same author

Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in Spain.

Future oncology (London, England)·2021
Same author

Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome.

Annals of hematology·2021
Same author

Risk factors and outcome of COVID-19 in patients with hematological malignancies.

Experimental hematology & oncology·2020

Platelet function is abnormal in primary thrombocythemia (PT) patients. The PFA-100 test effectively detects these platelet abnormalities, showing prolonged closure times, which may aid in PT diagnosis.

Area of Science:

  • Hematology
  • Clinical Pathology

Background:

  • Primary thrombocythemia (PT) is a myeloproliferative neoplasm characterized by elevated platelet counts.
  • Platelet dysfunction is often observed in PT, but its comprehensive assessment can be challenging.

Purpose of the Study:

  • To evaluate platelet function in patients with primary thrombocythemia using standard aggregometry and the PFA-100 assay.
  • To determine if the PFA-100 assay can reliably detect platelet function abnormalities in PT.

Main Methods:

  • Platelet function was assessed in 55 PT patients and 26 healthy volunteers using aggregometric tests and the PFA-100 (collagen-ADP and collagen-epinephrine cartridges).
  • Plasma von Willebrand factor (vWF) levels were also measured.

Main Results:

Related Experiment Videos

  • The PFA-100 assay revealed significantly prolonged closure times in PT patients compared to controls for both collagen-epinephrine (69% abnormal) and collagen-ADP (42% abnormal) cartridges.
  • Standard aggregometry showed decreased platelet response to epinephrine (58% affected) and collagen (38% affected).
  • Plasma vWF levels were normal in PT patients.

Conclusions:

  • Platelet function is demonstrably abnormal in patients with primary thrombocythemia.
  • The PFA-100 assay is a sensitive, reproducible, and easy-to-use method for assessing platelet dysfunction in PT.
  • Prolonged closure times observed with the PFA-100 assay may serve as a diagnostic marker for PT.